You are here
- Home
- topic
- BMJ Open Respiratory Research
- BMJ Open Respiratory Research
- Interstitial lung disease
Interstitial lung disease
- First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiativeNynke A Kampstra, Jan C Grutters, Frouke T van Beek, Daniel A Culver, Robert P Baughman, Elisabetta A Renzoni, Wim Wuyts, Vaslis Kouranos, Marlies S Wijsenbeek, Douwe H Biesma, Philip J van der Wees, Paul B van der NatBMJ Open Respiratory Research Feb 2019, 6 (1) e000394; DOI: 10.1136/bmjresp-2018-000394
- Sarcoidosis in the UK: insights from British Thoracic Society registry dataMuhunthan Thillai, William Chang, Nazia Chaudhuri, Ian Forrest, Ling-Pei Ho, Sarah Lines, Toby M Maher, Lisa G Spencer, Monica Spiteri, Robina CokerBMJ Open Respiratory Research Feb 2019, 6 (1) e000357; DOI: 10.1136/bmjresp-2018-000357
- Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trialsLisa Lancaster, Bruno Crestani, Paul Hernandez, Yoshikazu Inoue, Daniel Wachtlin, Lazaro Loaiza, Manuel Quaresma, Susanne Stowasser, Luca RicheldiBMJ Open Respiratory Research Mar 2019, 6 (1) e000397; DOI: 10.1136/bmjresp-2018-000397
- Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)Toby M Maher, Michael Kreuter, David J Lederer, Kevin K Brown, Wim Wuyts, Nadia Verbruggen, Simone Stutvoet, Ann Fieuw, Paul Ford, Walid Abi-Saab, Marlies WijsenbeekBMJ Open Respiratory Research May 2019, 6 (1) e000422; DOI: 10.1136/bmjresp-2019-000422
- Psychological burden associated with worse clinical outcomes in sarcoidosisMichelle Sharp, Taylor Brown, Edward Chen, Cynthia S Rand, David R Moller, Michelle N EakinBMJ Open Respiratory Research Sep 2019, 6 (1) e000467; DOI: 10.1136/bmjresp-2019-000467
- ‘It’s difficult, it’s life changing what happens to you’ patient perspective on life with chronic hypersensitivity pneumonitis: a qualitative studyKerri I Aronson, Bradley J Hayward, Laura Robbins, Robert J Kaner, Fernando J Martinez, Monika M SaffordBMJ Open Respiratory Research Dec 2019, 6 (1) e000522; DOI: 10.1136/bmjresp-2019-000522
- Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic studyYidan D Zhao, Li Yin, Stephen Archer, Catherine Lu, George Zhao, Yan Yao, Licun Wu, Michael Hsin, Thomas K Waddell, Shaf Keshavjee, John Granton, Marc de PerrotBMJ Open Respiratory Research Jun 2017, 4 (1) e000183; DOI: 10.1136/bmjresp-2017-000183
- Clinical use of nintedanib in patients with idiopathic pulmonary fibrosisAmy Hajari Case, Peace JohnsonBMJ Open Respiratory Research Jun 2017, 4 (1) e000192; DOI: 10.1136/bmjresp-2017-000192
- Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung diseaseKevin R Flaherty, Kevin K Brown, Athol U Wells, Emmanuelle Clerisme-Beaty, Harold R Collard, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Florence Le Maulf, Luca Richeldi, Hendrik Schmidt, Simon Walsh, William Mezzanotte, Rozsa Schlenker-HercegBMJ Open Respiratory Research Sep 2017, 4 (1) e000212; DOI: 10.1136/bmjresp-2017-000212
- Predictors of postoperative acute exacerbation of interstitial lung disease: a case–control studyKeisuke Hosoki, Yu Mikami, Hirokazu Urushiyama, Kunihiko Souma, Gaku Kawamura, Kanji Uchida, Takahide Nagase, Taisuke JoBMJ Open Respiratory Research Oct 2020, 7 (1) e000634; DOI: 10.1136/bmjresp-2020-000634
Pages
- BMJ Open Respiratory Research
- Cough (3)
- Critical care (8)
- Cystic fibrosis (3)
- Lung cancer (9)
- Sleep (2)
- Thoracic surgery (1)
- Tuberculosis (2)